Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review
Cluster of differentiation (CD) 24, a long-known protein with multifaceted functions, has gained attention as a possible treatment for Coronavirus Disease 19 (COVID-19) due to its known anti-inflammatory action. Extracellular vesicles (EVs), such as exosomes and microvesicles, may serve as candidate...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/12/10/1472 |
| _version_ | 1827649371485765632 |
|---|---|
| author | Georgios Tsioulos Ioannis Grigoropoulos Charalampos D. Moschopoulos Shiran Shapira Garyfallia Poulakou Anastasia Antoniadou Dimitrios Boumpas Nadir Arber Sotirios Tsiodras |
| author_facet | Georgios Tsioulos Ioannis Grigoropoulos Charalampos D. Moschopoulos Shiran Shapira Garyfallia Poulakou Anastasia Antoniadou Dimitrios Boumpas Nadir Arber Sotirios Tsiodras |
| author_sort | Georgios Tsioulos |
| collection | DOAJ |
| description | Cluster of differentiation (CD) 24, a long-known protein with multifaceted functions, has gained attention as a possible treatment for Coronavirus Disease 19 (COVID-19) due to its known anti-inflammatory action. Extracellular vesicles (EVs), such as exosomes and microvesicles, may serve as candidate drug delivery platforms for novel therapeutic approaches in COVID-19 and various other diseases due to their unique characteristics. In the current review, we describe the physiology of CD24 and EVs and try to elucidate their role, both independently and as a combination, in COVID-19 therapeutics. CD24 may act as an important immune regulator in diseases with complex physiologies characterized by excessive inflammation. Very recent data outline a possible therapeutic role not only in COVID-19 but also in other similar disease states, e.g., acute respiratory distress syndrome (ARDS) and sepsis where immune dysregulation plays a key pathophysiologic role. On the other hand, CD24, as well as other therapeutic molecules, can be administered with the use of exosomes, exploiting their unique characteristics to create a novel drug delivery platform as outlined in recent clinical efforts. The implications for human therapeutics in general are huge with regard to pharmacodynamics, pharmacokinetics, safety, and efficacy that will be further elucidated in future randomized controlled trials (RCTs). |
| first_indexed | 2024-03-09T19:56:25Z |
| format | Article |
| id | doaj.art-47155fe8369b4be4aae3279173ff7222 |
| institution | Directory Open Access Journal |
| issn | 2075-1729 |
| language | English |
| last_indexed | 2024-03-09T19:56:25Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj.art-47155fe8369b4be4aae3279173ff72222023-11-24T00:55:28ZengMDPI AGLife2075-17292022-09-011210147210.3390/life12101472Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative ReviewGeorgios Tsioulos0Ioannis Grigoropoulos1Charalampos D. Moschopoulos2Shiran Shapira3Garyfallia Poulakou4Anastasia Antoniadou5Dimitrios Boumpas6Nadir Arber7Sotirios Tsiodras84th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, Greece4th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, Greece4th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, GreeceIntegrated Cancer Prevention Center, Tel Aviv Medical Center, Tel Aviv 6423906, Israel3rd Department of Internal Medicine, Medical School, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece4th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, Greece4th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, GreeceIntegrated Cancer Prevention Center, Tel Aviv Medical Center, Tel Aviv 6423906, Israel4th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, GreeceCluster of differentiation (CD) 24, a long-known protein with multifaceted functions, has gained attention as a possible treatment for Coronavirus Disease 19 (COVID-19) due to its known anti-inflammatory action. Extracellular vesicles (EVs), such as exosomes and microvesicles, may serve as candidate drug delivery platforms for novel therapeutic approaches in COVID-19 and various other diseases due to their unique characteristics. In the current review, we describe the physiology of CD24 and EVs and try to elucidate their role, both independently and as a combination, in COVID-19 therapeutics. CD24 may act as an important immune regulator in diseases with complex physiologies characterized by excessive inflammation. Very recent data outline a possible therapeutic role not only in COVID-19 but also in other similar disease states, e.g., acute respiratory distress syndrome (ARDS) and sepsis where immune dysregulation plays a key pathophysiologic role. On the other hand, CD24, as well as other therapeutic molecules, can be administered with the use of exosomes, exploiting their unique characteristics to create a novel drug delivery platform as outlined in recent clinical efforts. The implications for human therapeutics in general are huge with regard to pharmacodynamics, pharmacokinetics, safety, and efficacy that will be further elucidated in future randomized controlled trials (RCTs).https://www.mdpi.com/2075-1729/12/10/1472COVID-19exosomesCD24 |
| spellingShingle | Georgios Tsioulos Ioannis Grigoropoulos Charalampos D. Moschopoulos Shiran Shapira Garyfallia Poulakou Anastasia Antoniadou Dimitrios Boumpas Nadir Arber Sotirios Tsiodras Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review Life COVID-19 exosomes CD24 |
| title | Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review |
| title_full | Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review |
| title_fullStr | Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review |
| title_full_unstemmed | Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review |
| title_short | Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review |
| title_sort | insights into cd24 and exosome physiology and potential role in view of recent advances in covid 19 therapeutics a narrative review |
| topic | COVID-19 exosomes CD24 |
| url | https://www.mdpi.com/2075-1729/12/10/1472 |
| work_keys_str_mv | AT georgiostsioulos insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT ioannisgrigoropoulos insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT charalamposdmoschopoulos insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT shiranshapira insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT garyfalliapoulakou insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT anastasiaantoniadou insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT dimitriosboumpas insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT nadirarber insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview AT sotiriostsiodras insightsintocd24andexosomephysiologyandpotentialroleinviewofrecentadvancesincovid19therapeuticsanarrativereview |